RxDoctor Payments Data

William Culclasure, PA

Physician Assistant · Columbia, SCNPI 1205878410

Payments from drug & device makers

$846in general payments, 2019–2025

Across 47 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$220
  • Boehringer Ingelheim$145
  • AbbVie$102
  • Lilly USA, LLC$72
  • Novo Nordisk$51
  • Corcept Therapeutics$49
  • plus $207 from 8 others

What the payments were for

  • Food & beverage$846100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$846 in reported general payments places this provider in the 60th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$129,044
Medicare patients
136
Services billed
1,947

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban81$52,731
JardianceEmpagliflozin68$50,982
FarxigaDapagliflozin Propanediol59$41,815
JanuviaSitagliptin Phosphate43$30,425
XareltoRivaroxaban44$28,568
TrulicityDulaglutide19$27,815
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$21,398
OzempicSemaglutide21$21,314
MyrbetriqMirabegron39$19,899
CreonLipase/Protease/Amylase14$13,992
RybelsusSemaglutide11$12,970
LinzessLinaclotide15$11,695
Spiriva RespimatTiotropium Bromide17$9,332
Atorvastatin Calcium560$8,650
EntrestoSacubitril/Valsartan13$8,399

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$145$60,31485 claims
PfizerEliquis$45$52,73181 claims
AstraZenecaFarxiga, Symbicort$220$47,58883 claims
MerckJanuvia, Belsomra$29$36,54956 claims
Novo NordiskOzempic, Rybelsus$51$34,28332 claims
Lilly USA, LLCTrulicity, Olanzapine$72$31,522160 claims
AbbVieCreon, Linzess$102$25,68629 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →